Dorsey Wright & Associates Aeglea Bio Therapeutics, Inc. Transaction History

Dorsey Wright & Associates

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 28, 2020	SELL	$6.51 - $9.33 $7,532 - $10,794	-1,157 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$4.01 - $11.04 $4,639 - $12,773	1,157 New	1,157 $11,000
Q2 2019 Jul 02, 2019	SELL	$6.1 - $8.78 $4,977 - $7,164	-816 Closed	0 $0
Q1 2019 Apr 04, 2019	SELL	$7.6 - $9.4 $6,201 - $7,670	-816 Reduced 50.0%	816 $7,000
Q4 2018 Jan 07, 2019	BUY	$6.51 - $10.19 $1,770 - $2,771	272 Added 20.0%	1,632 $12,000
Q3 2018 Oct 12, 2018	BUY	$8.24 - $11.0 $11,206 - $14,960	1,360 New	1,360 $13,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Dorsey Wright & Associates, based on Form 13F filings with the SEC.

Stay updated on Dorsey Wright & Associates with notifications on news.